Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDE4A | P27815 | 1/20 | 0.51 |
| ▸ | PDE4B | Q07343 | 1/20 | 0.51 |
| ▸ | PDE4C | Q08493 | 1/20 | 0.51 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.51 |
| ▸ | HDAC6 | Q9UBN7 | 2/20 | 0.51 |
| ▸ | CRBN | Q96SW2 | 2/20 | 0.47 |
| ▸ | LMNA | P02545 | 1/20 | 0.46 |
| ▸ | AVPR1A | P37288 | 4/20 | 0.44 |
| ▸ | AVPR2 | P30518 | 3/20 | 0.44 |
| ▸ | OXTR | P30559 | 3/20 | 0.44 |
| ▸ | TSHR | P16473 | 3/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.41 |
| ▸ | AVPR1B | P47901 | 1/20 | 0.40 |
| ▸ | ROCK2 | O75116 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7148650 | 0.91 | HDAC6 (0.52) | PDE4APDE4BPDE4CPDE4DHDAC6 | |
| SCHEMBL7556961 | 0.90 | CRBN (0.46) | PDE4APDE4BPDE4CPDE4DHDAC6 | |
| SCHEMBL7018541 | 0.83 | PDE4A (0.73) | PDE4APDE4BPDE4CPDE4DLMNA | |
| SCHEMBL7022861 | 0.81 | PDE4A (0.47) | PDE4APDE4BPDE4CPDE4DHDAC6 | |
| SCHEMBL7019736 | 0.80 | PDE4A (0.52) | PDE4APDE4BPDE4CPDE4DLMNA | |
| SCHEMBL7016608 | 0.80 | PDE4A (0.53) | PDE4APDE4BPDE4CPDE4DLMNA | |
| SCHEMBL7020949 | 0.80 | PDE4A (0.53) | PDE4APDE4BPDE4CPDE4DLMNA | |
| SCHEMBL7016731 | 0.79 | HDAC6 (0.45) | PDE4APDE4BPDE4CPDE4DHDAC6 | |
| Hydrochloric Acid SCHEMBL7027051 | 0.78 | HDAC6 (0.45) | PDE4APDE4BPDE4CPDE4DHDAC6 | |
| SCHEMBL7021322 | 0.77 | PDE4A (0.55) | PDE4APDE4BPDE4CPDE4DLMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1051415-B1 | BENZAMIDE DERIVATIVES AS VASOPRESSIN ANTAGONISTS | FUJISAWA PHARMACEUTICAL CO (JP) | 2003-09-24 | — | — | EP | disclosed |
| US-6495542-B1 | SUCH AS 2-METHOXY-N-(2-METHYL-1H-BENZIMIDAZOL-4-YL)-4-(2,3,4,5-TETRAHYDRO-5-OXO-1H-1-BENZAZEPIN-1-YL)CARBONYL-BENZAM IDE; HYPERTENSION, HEART FAILURE, RENAL INSUFFICIENCY, EDEMA, ASCITES, VASOPRESSIN PARASECRETION SYNDROME | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 2002-12-17 | — | — | US | disclosed |